The U.S. Food and Drug Administration has approved the marketing of a new tool that can test a person’s blood to diagnose ...

However, that could all change thanks to a new blood test called Lumipulse. On May 16, the U.S. Food & Drug Administration (FDA) approved the first-ever Alzheimer’s blood test. Lumipulse is the ...

The Lumipulse test has specifically been approved to help diagnose the disease in the clinical setting. Dr. Amanada Smith said that makes it the first and only test with that advantage.

A simple blood draw has now become a powerful tool in the early fight against Alzheimer’s. The FDA has approved the first ...

The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...

The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...

The medications have been dogged by complications such as bleeding in the brain. The FDA cleared Lumipulse for patients at least 55 years old with symptoms of the disease, based on a clinical ...

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and beta-amyloid 1-42 in plasma.

Dr. Richard G. Stefanacci explains why the FDA's recent clearance of a diagnostic blood test for Alzheimer's deserves ...

FDA Commissioner Martin Makary said 10% of people aged 65 and older have Alzheimer's. "I am hopeful that new medical products such as this one will help patients," Makary said. The Lumipulse blood ...

The FDA says that it is "intended for patients ... at 97.3% of patients. "We designed our Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio test to help physicians and patients with signs and ...

The test, called the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, is for adults 55 and older who are showing signs and symptoms of Alzheimer’s disease, the FDA announced Friday. It works by ...